ClinicalTrials.govpublic full text
Analysing the Effect of Empagliflozin on Reduction of Tissue Sodium Content in Patients With Chronic Heart Failure
chronic heart failure, sglt-2 inhibitor, chronic heart failure, tissue sodium,, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 914338
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.